NCT05309668 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- All-cause mortality (death due to any cause): from first dose of study medication up to and including the data cut-off 1 analysis (08Apr2024), up to 26 months. Treatment-emergent adverse events: from first dose of study medication up to and including 30 days after the last dose of selumetinib, an average of 12.6 months.
- Other-event reporting threshold
- 5%
All-cause mortality was reported for all subjects. Adverse events were reported for subjects who received at least one dose of study drug, and includes AEs that start prior to and worsen after treatment or with an onset or worsening date on or after the date of first selumetinib dose up to and including 30 days after the date of last selumetinib dose.
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Global Cohort 1 | 1 / 15 | 15 / 15 | 0 / 15 |
| Global Cohort 2 | 1 / 17 | 17 / 17 | 0 / 17 |
| Total in Global | 2 / 32 | 32 / 32 | 0 / 32 |
| Japan Cohort | 0 / 4 | 4 / 4 | 0 / 4 |
| Total in Study | 2 / 36 | 36 / 36 | 0 / 36 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Pyrexia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Gastroenteritis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Upper respiratory tract infection
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 32
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 36
- num Events
- 2
- term
- Abdominal pain upper
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 32
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 36
- num Events
- 2
- term
- Irritability
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Staring
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Haemoglobinuria
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Proteinuria
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Catarrh
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 3
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 17
- num Events
- 3
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 32
- num Events
- 6
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 36
- num Events
- 6
- term
- Cough
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 17
- num Events
- 2
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 32
- num Events
- 3
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 36
- num Events
- 3
- term
- Epistaxis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 2
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 2
- term
- Productive cough
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Respiratory disorder
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 17
- num Events
- 4
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 32
- num Events
- 5
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 4
- num At Risk
- 36
- num Events
- 5
- term
- Rhinorrhoea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Anal fissure
Complete source fields
- description
- All-cause mortality was reported for all subjects. Adverse events were reported for subjects who received at least one dose of study drug, and includes AEs that start prior to and worsen after treatment or with an onset or worsening date on or after the date of first selumetinib dose up to and including 30 days after the date of last selumetinib dose.
- event Groups
- deaths Num Affected
- 0
- deaths Num At Risk
- 15
- description
- Global Cohort 1 (\>=4 to \<7 years)
- id
- EG000
- other Num Affected
- 15
- other Num At Risk
- 15
- serious Num Affected
- 1
- serious Num At Risk
- 15
- title
- Global Cohort 1
- deaths Num Affected
- 0
- deaths Num At Risk
- 17
- description
- Global Cohort 2 (\>=1 to \<4 years)
- id
- EG001
- other Num Affected
- 17
- other Num At Risk
- 17
- serious Num Affected
- 1
- serious Num At Risk
- 17
- title
- Global Cohort 2
- deaths Num Affected
- 0
- deaths Num At Risk
- 32
- description
- Global Cohorts (\>=1 to \<7 years)
- id
- EG002
- other Num Affected
- 32
- other Num At Risk
- 32
- serious Num Affected
- 2
- serious Num At Risk
- 32
- title
- Total in Global
- deaths Num Affected
- 0
- deaths Num At Risk
- 4
- description
- Japan Cohort (\>=1 to \<7 years)
- id
- EG003
- other Num Affected
- 4
- other Num At Risk
- 4
- serious Num Affected
- 0
- serious Num At Risk
- 4
- title
- Japan Cohort
- deaths Num Affected
- 0
- deaths Num At Risk
- 36
- description
- Total in study (\>=1 to \<7 years)
- id
- EG004
- other Num Affected
- 36
- other Num At Risk
- 36
- serious Num Affected
- 2
- serious Num At Risk
- 36
- title
- Total in Study
- frequency Threshold
- 5
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 32
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 36
- num Events
- 2
- term
- Abdominal pain upper
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 32
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 2
- num At Risk
- 36
- num Events
- 2
- term
- Irritability
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Staring
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Haemoglobinuria
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Proteinuria
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Catarrh
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 3
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 17
- num Events
- 3
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 32
- num Events
- 6
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 36
- num Events
- 6
- term
- Cough
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 17
- num Events
- 2
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 32
- num Events
- 3
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 36
- num Events
- 3
- term
- Epistaxis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 2
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 2
- term
- Productive cough
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Respiratory disorder
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 17
- num Events
- 4
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 32
- num Events
- 5
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 4
- num At Risk
- 36
- num Events
- 5
- term
- Rhinorrhoea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Anal fissure
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 17
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Pyrexia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Gastroenteritis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 26.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 17
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 32
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 36
- num Events
- 1
- term
- Upper respiratory tract infection
- time Frame
- All-cause mortality (death due to any cause): from first dose of study medication up to and including the data cut-off 1 analysis (08Apr2024), up to 26 months. Treatment-emergent adverse events: from first dose of study medication up to and including 30 days after the last dose of selumetinib, an average of 12.6 months.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle